CDC Multi-plex ELISA and Vaccine Immunogenicity: HPV Serology

Organization

Centers for Disease Control and Prevention (CDC)

Centers for Disease Control and Prevention (CDC)

CDC-

• An application
• Transcripts –  for detailed information about acceptable transcripts
• A current resume/CV, including academic history, employment history, relevant experiences, and publication list
• One educational or professional recommendation. Your application will be considered incomplete, and will not be reviewed until one recommendation is submitted.

9/25/2026 3:00:00 PM Eastern Time Zone

Applications will be reviewed on a rolling-basis.

A research participation opportunity is available in the Chronic Viral Diseases Branch (CVDB), Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia.

The Centers for Disease Control and Prevention (CDC) is one of the major operation components of the Department of Health and Human Services. CDC protects America from health, safety and security threats, both foreign and in the U.S. Whether diseases start at home or abroad, are chronic or acute, curable or preventable, human error or deliberate attack, CDC fights disease and supports communities and citizens to do the same.

CDC increases the health security of our nation. As the nation’s health protection agency, CDC saves lives and protects people from health threats. To accomplish its mission, CDC conducts important science and provides health information that protects our nation against expensive and dangerous health threats, and responds when these arise.

The Chronic Viral Diseases Branch (CVDB) is located within the Division of High-Consequence Pathogens and Pathology (DHCPP), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia. CVDB conducts research on chronic fatigue syndrome (ME/CFS) and human papillomavirus (HPV) with the goal of reducing the health burden of these conditions through excellence in population-based epidemiology, laboratory research, and public health education.

CVDB’s HPV laboratory program supports molecular genotyping, serology, sequencing-based methods, assay evaluation, and surveillance activities that contribute to monitoring HPV infection, HPV-associated disease, and HPV vaccine impact.

A research participation opportunity is available in the Chronic Viral Diseases Branch HPV Immunology Laboratory for a master's-level participant interested in HPV serology, immunology, and public health laboratory science. This project contributes to CVDB's HPV serology program by applying the M9

ELISA multiplex virus-like particle IgG assay on the Meso Scale Discovery platform to support HPV vaccine immunogenicity studies, seroepidemiology, and assay quality activities. Under mentor guidance, you will gain experience with antigen preparation concepts, specimen processing workflows, HPV antibody testing, assay controls, laboratory documentation, and data interpretation approaches used in serology research. The project may also include exposure to DNA purification, cell-culture-derived HPV virus-like particle production concepts, specimen tracking systems, and analysis of serology or assay performance data using Excel, R, or related laboratory data systems.

This research aligns with CVDB's public health mission by strengthening methods that help characterize immune responses to HPV infection and vaccination and support monitoring of HPV vaccine impact.

Research involving infectious agents or human biological specimens requires completion of CDC Form 0.838 prior to beginning the appointment.

• Gain experience in HPV serology concepts, including M9
  
  ELISA assay design, virus-like particle antigens, assay controls, and antibody response assessment.
• Learn specimen processing, tracking, storage, and documentation practices used for human biological specimens in public health laboratory research.
• Gain exposure to HPV antigen…